GlassScriptPhysician profile
Mohammad I Hussain
NPI 1699773747
$18,888.02
in general payments reported to CMS, 2019-2025
58 companies · $2,906 in 2025
The $2,906 reported for 2025 was more than what 78% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,466 · 2020: $3,404 · 2021: $2,707 · 2022: $1,695 · 2023: $1,637 · 2024: $3,073 · 2025: $2,906.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,616.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,616.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $2,221.03 | 2019-2025 | Briviact, Nayzilam, Fintepla |
| Biogen, INC. | $1,465.13 | 2019-2025 | Vumerity, Tysabri, Avonex |
| Livanova USA, INC. | $1,312.40 | 2019-2023 | Vns Therapy Sentiva Model 1000 Generator |
| Neurelis, INC. | $1,166.91 | 2021-2025 | Valtoco |
| Novartis Pharmaceuticals Corporation | $1,154.73 | 2019-2025 | |
| Abbvie INC. | $1,137.91 | 2021-2025 | |
| Alexion Pharmaceuticals, INC. | $936.88 | 2019-2024 | Ultomiris, Soliris |
| Microvention, INC. | $891.67 | 2020 | |
| Lundbeck LLC | $830.12 | 2019-2025 | Vyepti, Rexulti |
| Eisai INC. | $809.06 | 2019-2024 | |
| Amgen INC. | $550.04 | 2019-2025 | Uplizna, Aimovig |
| Kyowa Kirin, INC. | $489.64 | 2019-2024 | Nourianz |
| Allergan, INC. | $488.72 | 2020-2021 | |
| Neurocrine Biosciences, INC. | $474.21 | 2020-2025 | Ingrezza, Ongentys |
| Tg Therapeutics, INC. | $428.56 | 2023-2025 |
Show all 58 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Hussain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.